150
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Lacrimal Gland Uptake of 67Ga-gallium Citrate Correlates with Biopsy Results in Patients with Suspected Sarcoidosis

, MD, JD, , MD, PhD, , MD, , MD, , MD, , PhD, , MD, , MD & , MD show all
Pages 15-22 | Received 18 Sep 2012, Accepted 21 Mar 2013, Published online: 03 Jun 2013
 

Abstract

Purpose: To investigate whether lacrimal gland uptake on 67Ga-gallium citrate scintigraphy correlates with histopathologic evidence of sarcoidosis.

Methods: A retrospective, pilot study of 31 patients with suspected sarcoidosis who underwent gallium scintigraphy and lacrimal gland biopsy. Lacrimal gland gallium uptake was assessed by subjective visual scoring (SVS) and lacrimal uptake ratio (LUR).

Results: Eleven (36%) patients had lacrimal gland biopsies containing noncaseating granulomas. A statistically significant correlation was found between lacrimal gland gallium uptake and biopsy positivity using SVS (p = 0.03) or LUR (p = 0.01). Using SVS, biopsy positivity rate increased from 0 to 50% in patients with mild to intense uptake. Using LUR, biopsy positivity rate increased linearly as the ratio increased from 13% (LUR < 4) to 100% (LUR > 8).

Conclusions: Lacrimal biopsy positivity rate significantly correlated with gallium uptake on scintigraphy. Both SVS and LUR methods appear to correlate with histologic results and may potentially aid in patient selection for biopsy.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.